Last updated: November 16, 2025
Table Of Contents

Stoma

A stoma is an opening from a hollow viscus connecting it to the skin surface.

Stoma” = opening.

“Ostomy” = surgical creation of an artificial opening.

Ostomy is performed when it is unwise to restore/maintain the continuity of intestines.

Definition of terms

TermDefinition
StomaOpening from a hollow viscus connecting it to the skin surface
-ostomySurgical creation of an artificial opening
GastrostomyExternal opening into the stomach. Maintained by inserting a tube
IleostomyExternal opening in the small intestine
ColostomyExternal opening in the large intestine
UrostomyExternal opening in the urinary tract

Colosomy vs Ileostomy

IleostomyColostomy
SiteRight iliac fossaLeft iliac fossa
AppearanceSpoutedFlushed
EffleuntLiquidSolid
Common complicationsFluid and electrolyte imbalance, excoriation
Bag changeDrainable bags changed every 48 hoursChanged 2 – 3 times a day
  • Site for stoma
    • If not marked pre-operatively by a stoma therapist mark with indelible pen
    • Avoid bony areas, creases and previous scars
    • Should be visible to the patient and on a flat surface
    • If there is a panus the stoma is sited above it
    • Position the stoma within a triangle formed by the anterior superior iliac line (ASIS), umbilicus and the pubic symphysis in the right iliac fossa (ileostomy) or left iliac fossa (colostomy)
    • At least 5 cm from incision sites (far from midline incision in ex-lap), bony prominences (iliac crest, ASIS and costal margin), natural scars (the umbilicus), body folds and belt-line
    • Ideally the stoma should be brough out through the fibres of the rectus abdominis to reduce the risk fo parastomal hernia
    • Either side of the midline (but preferrably on the right)
  • Types of stomas according to duration
    • Permanent stoma
    • Temporary stoma
  • Types of stomas according to structure
    • Jejunostomy
    • Ileostomy
    • Cecostomy
    • Colostomy
    • Urostomy
  • Classification of stomas
    • End ileostomy or urostomy: spouted (to reduce irritation), red-pink, velvety surface, mucosal folds visible
    • End colostomy: flushed, pale-pink, smooth surface, few mucosal folds
    • Loop ileostomy: mucosal bridge (efferent loop inactive, afferent loop activ is spouted)
    • Loop colostomy: mucosal bridge
    • Barrel stoma: no mucosal bridge
  • Indications for temporary stomas
    • Inability to swallow post CVA (gastrostomy)
    • High risk of anastomotic leakage
    • Fecal peritonitis (loop colostomy)
    • Penetrating injury to the rectum and colon (end colostomy)
    • Rectovaginal fistula (loop colostomy)
    • Fecal incontinence
    • Complex Perianal fistulas
    • Sigmoid colectomy for complications of carcinoma or diverticulitis (Hartmann’s procedure, end colostomy)
  • Indications for permanent stomas
    • Permanent loss of swallowing e.g. multiple sclerosis, motor neuron disease (gastrostomy)
    • Total abdominal proctocolectomy for severe IBD (end ileostomy)
    • Abdominal-perineal resection (APR) for anorectal cancer or low rectal carcinoma (end colostomy)
    • Advanced obstructive rectal tumors (end colostomy)
  • End stoma
    • Bowel is completely divided
    • Proximal end sutured to abdominal wall. Distal end stumped, left in abdomen or removed.
    • Proximal end → drains feces
  • Loop stoma
    • Bowel is partially divided
    • Both openings sutured to abdominal wall
    • Proximal end → drains feces
    • Distal end → drains mucus
  • Double barrel
    • Bowel is completely divided
    • Both ends are sutured to the abdomen
  • Complications of stomas
    • Stoma necrosis
    • Significant stomal bleeding
    • Retraction
    • Stenosis
    • Parastomal hernia
    • Prolapse
    • Parastomal skin dermatitis
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *